Bi, Nan
Liu, Lipin
Liang, Jun
Wu, Shixiu
Chen, Ming
Lv, Changxing
Zhao, Lujun
Shi, Anhui
Jiang, Wei
Xu, Yaping
Zhou, Zongmei
Wang, Jingbo
Wang, Wenqing
Chen, Dongfu
Hui, Zhouguang
Lv, Jima
Zhang, Hongxing
Feng, Qinfu
Xiao, Zefen
Wang, Xin
Zhang, Tao
Yin, Weibo
Li, Junling
He, Jie
Wang, Luhua
Funding for this research was provided by:
CAMS Initiative for Innovative Medicine (2017-I2M-1-005)
Article History
Received: 12 May 2019
Accepted: 23 March 2020
First Online: 6 April 2020
Ethics approval and consent to participate
: The research protocol for phase 3 study was reviewed and approved by the Ethics Committee of Cancer Institute and Hospital Board Affiliation of Chinese Academy of Medical Sciences (07–10/213). All patients provided written informed consent prior to participation, including for audio-recording of interviews and telephone consultations.
: Not applicable.
: The authors declare that they have no competing interests.